Behavioral sensitization to beta-phenylethylamine (PEA): enduring modifications of specific dopaminergic neuron systems in the rat. 1990

T Kuroki, and T Tsutsumi, and M Hirano, and T Matsumoto, and Y Tatebayashi, and K Nishiyama, and H Uchimura, and A Shiraishi, and T Nakahara, and K Nakamura
Center for Emotional and Behavioral Disorders, Hizen National Mental Hospital, Saga, Japan.

Repeated daily administration of an endogenous trace amine, beta-phenylethylamine (PEA), produces behavioral sensitization such that the intensity of PEA-induced stereotyped behaviors in rats increases gradually during the treatment, and a challenge injection with PEA reinstates the enhanced stereotypy even long after withdrawal. In the present study, we examined the neurochemical changes in the central dopaminergic neurons systems in the rat for 7 drug-free days after repeated treatment with PEA (50 mg/kg, IP day for 14 or 28 days). During withdrawal, a decrease in steady-state levels of tissue dopamine (DA) and its metabolite, dihydroxyphenylacetic acid (DOPAC), was found in the mesolimbic DA nerve terminal areas of the rat brain receiving repeated PEA treatment. Fifteen minutes after challenge administration of PEA at varying doses from 6.3 to 75 mg/kg, the rats with repeated PEA treatment required smaller doses of PEA challenge than the rats with acute PEA treatment in order to obtain a significant decrease in striatal DOPAC content compared to the saline control in each treatment group. These results imply that the behavioral sensitization to PEA is accompanied by enduring modifications of the specific dopaminergic neuron systems in the rat brain. This suggestion was strongly supported by the results of the study using in vivo intracerebral dialysis, which indicated that 25 mg/kg PEA challenge elicited a remarkable increase in the extracellular DA concentrations in striatal perfusates collected from the PEA-pretreated rats, in accordance with the intensity of stereotyped behaviors. These findings argue that the hyper-responsiveness to PEA of the striatal dopaminergic neuron systems persists long after withdrawal from repeated treatment with PEA.

UI MeSH Term Description Entries
D008297 Male Males
D009411 Nerve Endings Branch-like terminations of NERVE FIBERS, sensory or motor NEURONS. Endings of sensory neurons are the beginnings of afferent pathway to the CENTRAL NERVOUS SYSTEM. Endings of motor neurons are the terminals of axons at the muscle cells. Nerve endings which release neurotransmitters are called PRESYNAPTIC TERMINALS. Ending, Nerve,Endings, Nerve,Nerve Ending
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D010627 Phenethylamines A group of compounds that are derivatives of beta- aminoethylbenzene which is structurally and pharmacologically related to amphetamine. (From Merck Index, 11th ed) Phenylethylamines
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D011954 Receptors, Dopamine Cell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behavior of cells. Dopamine Receptors,Dopamine Receptor,Receptor, Dopamine
D003956 Dialysis A process of selective diffusion through a membrane. It is usually used to separate low-molecular-weight solutes which diffuse through the membrane from the colloidal and high-molecular-weight solutes which do not. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Dialyses
D006719 Homovanillic Acid A 3-O-methyl ETHER of (3,4-dihydroxyphenyl)acetic acid. 3-Methoxy-4-Hydroxyphenylacetic Acid,4-Hydroxy-3-Methoxyphenylacetic Acid,3 Methoxy 4 Hydroxyphenylacetic Acid,4 Hydroxy 3 Methoxyphenylacetic Acid,Acid, 3-Methoxy-4-Hydroxyphenylacetic,Acid, 4-Hydroxy-3-Methoxyphenylacetic,Acid, Homovanillic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001522 Behavior, Animal The observable response an animal makes to any situation. Autotomy Animal,Animal Behavior,Animal Behaviors

Related Publications

T Kuroki, and T Tsutsumi, and M Hirano, and T Matsumoto, and Y Tatebayashi, and K Nishiyama, and H Uchimura, and A Shiraishi, and T Nakahara, and K Nakamura
January 1979, Neirofiziologiia = Neurophysiology,
T Kuroki, and T Tsutsumi, and M Hirano, and T Matsumoto, and Y Tatebayashi, and K Nishiyama, and H Uchimura, and A Shiraishi, and T Nakahara, and K Nakamura
January 1978, Advances in biochemical psychopharmacology,
T Kuroki, and T Tsutsumi, and M Hirano, and T Matsumoto, and Y Tatebayashi, and K Nishiyama, and H Uchimura, and A Shiraishi, and T Nakahara, and K Nakamura
September 1982, European journal of pharmacology,
T Kuroki, and T Tsutsumi, and M Hirano, and T Matsumoto, and Y Tatebayashi, and K Nishiyama, and H Uchimura, and A Shiraishi, and T Nakahara, and K Nakamura
December 1995, Brain research,
T Kuroki, and T Tsutsumi, and M Hirano, and T Matsumoto, and Y Tatebayashi, and K Nishiyama, and H Uchimura, and A Shiraishi, and T Nakahara, and K Nakamura
November 1974, Life sciences,
T Kuroki, and T Tsutsumi, and M Hirano, and T Matsumoto, and Y Tatebayashi, and K Nishiyama, and H Uchimura, and A Shiraishi, and T Nakahara, and K Nakamura
January 1984, Biological psychiatry,
T Kuroki, and T Tsutsumi, and M Hirano, and T Matsumoto, and Y Tatebayashi, and K Nishiyama, and H Uchimura, and A Shiraishi, and T Nakahara, and K Nakamura
June 1990, Digestive diseases and sciences,
T Kuroki, and T Tsutsumi, and M Hirano, and T Matsumoto, and Y Tatebayashi, and K Nishiyama, and H Uchimura, and A Shiraishi, and T Nakahara, and K Nakamura
December 1990, Biological psychiatry,
T Kuroki, and T Tsutsumi, and M Hirano, and T Matsumoto, and Y Tatebayashi, and K Nishiyama, and H Uchimura, and A Shiraishi, and T Nakahara, and K Nakamura
July 1973, Canadian journal of biochemistry,
T Kuroki, and T Tsutsumi, and M Hirano, and T Matsumoto, and Y Tatebayashi, and K Nishiyama, and H Uchimura, and A Shiraishi, and T Nakahara, and K Nakamura
November 1992, Pharmacology, biochemistry, and behavior,
Copied contents to your clipboard!